Remdesivir-induced severe hypoglycemia in an elderly man without diabetes: a case report
Abstract Background Remdesivir is recommended to treat hospitalized patients with coronavirus disease 2019 (COVID-19). Remdesivir is known to affect glucose metabolism in individuals with and without diabetes. However, little is known about the possibility of hypoglycemia associated with remdesivir....
Saved in:
Main Authors: | Yasunori Nagano, Hisae Aoki, Juri David, Naoko Iwahashi Kondo, Makimi Aizawa, Toshiyuki Sumita, Yuki Hamada, Yuki Yamamoto, Kaoru Yamada |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Pharmaceutical Health Care and Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40780-024-00406-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ecofriendly spectrophotometric methods for simultaneous determination of remdesivir and moxifloxacin hydrochloride as co administered drugs in corona virus treatment
by: Eman A. Madbouly, et al.
Published: (2025-01-01) -
Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
by: Yeon Ju La, et al.
Published: (2025-02-01) -
A Case of Persistent Hypoglycemia: Emphasizing the Role of Kidneys
by: Praveen Govindaraju, et al.
Published: (2024-04-01) -
Case report: Kabuki syndrome and persistent hypoglycemia in neonates
by: Osama Y Safdar, et al.
Published: (2024-12-01) -
Hypoglycemia and hospital mortality in critically ill patients
by: Hsuan-Fan Yeh, et al.
Published: (2025-01-01)